Flow cytometric analysis of BALB/c mouse splenocytes treated overnight with 3μg/ml Concanavalin A (Right) or untreated (Left), labeling CD25 at 1/2000 dilution (0.1 μg). Goat Anti - Rat IgG Alexa Fluor® 647 was used as the secondary antibody. Then cells were stained with CD4 - Alexa Fluor® 488 separately. Gated on total viable cells.
Mouse Anti-Rat CD25 Antibody (S-R676)
Mouse Anti-Rat CD25 Antibody (S-R676)
Price:
Regular price
$100.00 USD
Regular price
Sale price
$100.00 USD
Unit price
per
For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details
Product Details
Product Details
Product Specification
| Host | Mouse |
| Antigen | CD25 |
| Synonyms | Peripheral myelin protein 22; PMP-22; Protein CD25; SR13 myelin protein; Schwann cell membrane glycoprotein (SAG); Pmp22 |
| Location | Cell membrane |
| Accession | P25094 |
| Clone Number | S-R676 |
| Antibody Type | Mouse mAb |
| Isotype | IgG1,k |
| Application | FCM |
| Reactivity | Rt |
| Positive Sample | BALB/c mouse splenocytes treated overnight with 3μg/ml Concanavalin A |
| Purification | Protein G |
| Concentration | 2 mg/ml |
| Conjugation | Unconjugated |
| Physical Appearance | Liquid |
| Storage Buffer | PBS pH7.4 |
| Stability & Storage | 12 months from date of receipt / reconstitution, 2 to 8 °C as supplied. |
Dilution
| application | dilution | species |
| FCM | 1:2000 | Rt |
Background
CD25, also known as the interleukin-2 receptor alpha chain (IL-2Rα), is a membranous glycoprotein that forms the alpha chain of the IL-2 receptor complex. It is primarily expressed on activated T lymphocytes and plays a crucial role in regulating immune responses by mediating IL-2 signaling. When combined with IL-2Rβ and the common γ chain, CD25 forms a high-affinity receptor complex that enhances the binding and signaling of IL-2, promoting T-cell proliferation and activation. Additionally, CD25 is involved in the development and function of regulatory T cells, which help maintain immune tolerance and prevent autoimmune diseases. Abnormal expression of CD25 has been associated with various diseases, including autoimmune disorders and certain cancers, making it a potential target for therapeutic interventions.
Picture
Picture
FC
